TREATMENT OF INTERMEDIATE-OR HIGH-RISK PROSTATE CANCER BY DOSE ESCALATION WITH HIGH-DOSE 3D-CONFORMAL RADIOTHERAPY (HD-3D-CRT) OR LOW-DOSE 3D-CONFORMAL RADIOTHERAPY PLUS HDR BRACHYTHERAPY (LD-3D-CRT+HDR-B) : EARLY RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL

被引：0

作者：

Guix, B. ^{[1
]}

Bartrina, J. M. ^{[1
]}

Tello, J. I. ^{[1
]}

Sole, J. ^{[1
]}

Quinzanos, L. ^{[1
]}

Lacorte, T. ^{[1
]}

Leon, F. ^{[1
]}

Fernandez, J. ^{[1
]}

Henriquez, I. ^{[1
]}

Guix, I. ^{[1
]}

Galdon, G. ^{[1
]}

Espino, M. ^{[1
]}

机构：

[1] IMOR Fdn, Med Inst Radiotherapy & Oncol, Radiat Oncol, Prostate Canc Unit, Barcelona, Spain

来源：

RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1240

引用

页码：S418 / S418

页数：1

共 50 条

[21] High-dose external BEAM intensity-modulated radiotherapy (HD-IMRT) versus intensity-modulated radiotherapy plus HDR brachytherapy boost (LD-IMRT plus HDR-B) dose escalation for intermediate- or high-risk prostate cancer [J].

Guix, Ines ;

Maria Bartrina, Jose ;

Panichi, Marco ;

Ignacio Tello, Jose ;

Garcia, Ivan ;

Maria Del Campo, Jose ;

Quinzanos, Luis ;

Maria Lacorte, Teresa ;

Guix, Teresa ;

Guix, Benjamin ;

Guix, Benjamin .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)

[22] PHASE IIII TRIAL OF CETUXIMAB, CAPECITABINE, OXALIPLATIN AND 3D-CONFORMAL RADIOTHERAPY (3D-CRT) AS PREOPERATIVE TREATMENT IN RECTAL CANCER WITHOUT K-RAS MUTATIONS [J].

Troganis, N. ;

Varveris, C. ;

Mazonakis, M. ;

Varveris, A. ;

Lyraraki, E. .

RADIOTHERAPY AND ONCOLOGY, 2010, 96 :S267-S267

[23] Radiation dose to organs at risk in craniospinal irradiation: Conventional 3D-conformal radiotherapy vs. helical tomotherapy [J].

Devecka, M. ;

Duma, M. N. ;

Kampfer, S. ;

Hugo, C. ;

Geinitz, H. .

STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 :81-82

[24] 3D-CONFORMAL EXTERNAL RADIOTHERAPY (3D-CRT) GIVEN CONCURRENTLY WITH DOCETAXEL AND CISPLATINUM AS RADICAL TREATMENT FOR PATIENTS WITH INOPERABLE HIGH RISK ADENOCARCINOMA OF THE PROSTATE. A PHASE 1111 STUDY. [J].

Sakarelis, P. ;

Varveris, A. ;

Varveris, C. .

RADIOTHERAPY AND ONCOLOGY, 2010, 96 :S254-S254

[25] Early Results of 3D-Conformal Accelerated Partial Breast Irradiation Dose Escalation Phase II Trial at Gustave Roussy Institute [J].

Acevedo, C. ;

Heymann, S. ;

Levy, A. ;

Verstraet, R. ;

Delaloge, S. ;

Mathieu, M. C. ;

Gouy, S. ;

Taghian, A. G. ;

Marsiglia, H. ;

Bourgier, C. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02) :S240-S240

[26] Tolerance and efficacy of high-dose 3D-conformal radiation therapy (CRT) in cirrhotic patients with small hepatocellular carcinomas (HCC) not suitable for curative therapies [J].

Merle, P ;

Beziat, C ;

Wautot, V ;

Trepo, C ;

Mornex, F .

HEPATOLOGY, 2005, 42 (04) :394A-395A

[27] Comparison of Dose Parameters and Toxicity during neoadjuvant Chemoradiotherapy with 3D-conformal Radiotherapy or VMAT in Patients with Esophageal Cancer [J].

Muench, S. ;

Aichmeier, S. ;

Hapfelmeier, A. ;

Duma, M-N ;

Oechsner, M. ;

Feith, M. ;

Combs, S. E. ;

Habermehl, D. .

STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 :143-143

[28] Tolerance and efficacy of high-dose 3D-conformal radiation therapy (CRT) in cirrhotic patients with small hepatocellular carcinomas (HCC) not suitable for curative therapies [J].

Merle, P. ;

Beziat, C. ;

Wautot, V. ;

Kubas, A. ;

Khodri, M. ;

Bottigioli, D. ;

Trepo, C. ;

Mornex, F. .

RADIOTHERAPY AND ONCOLOGY, 2006, 81 :S529-S530

[29] Tolerance and efficacy of high-dose 3D-Conformal Radiation Therapy (CRT) in cirrhotic patients with small hepatocellular carcinomas (HCC) not suitable for curative therapies [J].

Mornex, F. ;

Merle, P. ;

Beziat, C. ;

Wautot, V. ;

Walter, T. ;

Kubas, A. ;

Khodri, M. ;

Bottigioli, D. ;

Trepo, C. .

EJC SUPPLEMENTS, 2005, 3 (02) :403-403

[30] Acute toxicity of high dose hypofractionated 3D conformal radiotherapy in localised prostate cancer [J].

Macias Hernandez, V. ;

Marcos-Pascua, P. ;

Pijls-Johannesma, M. ;

Modolell, I. ;

Gallardo, J. ;

Prats, J. ;

Macias, D. ;

Pardo, J. .

RADIOTHERAPY AND ONCOLOGY, 2006, 81 :S439-S440

← 1 2 3 4 5 →